drug
olatorepatide
Phase 2updated 6mo agoby $REGN REGENERON PHARMACEUTICALS, INC.
Phase 2community read0 votes
indications
indications
Obesity
all catalysts(0)
nothing on the calendar yet
Trials studying olatorepatide
- phase2Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
- phase2Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- phase2Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US
News(1)
- Regeneron achieves ‘clean sweep’ in Q3 with myriad pipeline catalysts on deckRegeneron executives struck an upbeat tone on an investor call Friday as the biotech posted a consensus-beating $5.1 billion in third quarter earnings and CEO Leonard Schleifer touted the company’s…biospace · 17d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that